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ABStrAct
Few studies in Nigeria have investigated the relationship between psychiatric disorders and 
substance use. Yet, evidence worldwide suggests that substance related problems might be a major 
burden among persons with psychiatric disorders.
One hundred and five persons with mental illness (105) were evaluated for substance use with 
the Alcohol, Smoking, and Substance Involvement screening test (ASSIST). A questionnaire was 
used to elicit Sociodemographic variables. A high proportion had initiated tobacco (50.9%) and 
cannabis (34.5%) during adolescent. Factors associated with hazardous drug consumption were 
male sex (p<0.05), younger age (p<0.05) unemployment (p<0.01) being unmarried (p<0.05) and 
lower educational level (p<0.05). Routine screening and brief interventions for substance use in 
psychiatric facilities should be critical components of mental health service delivery.
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introDuction
Several studies have reported that psychoac-
tive substance use is prevalent in Nigeria (Gure-
je et al., 2007; Adelekan, 1996; Obot 1990). Ac-
cording to the Nigeria Survey of Mental health 
and Wellbeing, some of the commonly used 
psychoactive substances include alcohol, tobac-
co and sedatives (Gureje et al., 2007). Substance 
use may co-occur with psychiatric disorders 
(Marshall and Farrell, 2007). This has been con-
sistently found in major epidemiological studies 
in western countries revealing higher prevalence 
rates of substance use disorders among persons 
with mental illness compared with the general 
population (Kessler et al., 1994 ; Regier et al., 
1990). 
The pattern and prevalence rates of sub-
stance use among persons with mental disor-
ders may vary widely (Wobrock et al., 2007; 
Haro et al., 2006). For instance, Koskinen et 
al., (2009) in a systematic review of 47 stud-
ies conducted in Western countries reported a 
range of 1-57% for alcohol use disorders in 
persons with Schizophrenia. In sub-Saharan 
Africa, higher rates of substance use have been 
reported among persons presenting for psy-
chiatric evaluation in mental health facilities 
(Hauli et al., 2011; Weich and Pienaar, 2009; 
Ndetei et al., 2008). For instance a recent study 
in Tanzania revealed that the prevalence rate 
of substance use in psychiatric populations 
may be as high as 68.5% (Hauli et al., 2011). 
This was lower than the prevalence of 74% 
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reported in a South African psychiatric facil-
ity (Weich and Pienaar, 2009). These widely 
varying rates have been attributed to differ-
ences in culture, geographical location and 
instruments used (Marshall & Farrell, 2004). 
Previous studies have identified some cor-
relates of substance use among persons with 
mental disorders (Hauli et al., 2011). In Tanza-
nia, family history of substance use was asso-
ciated with use of any psychoactive substance 
while secondary school level of education was 
significantly related to tobacco and cannabis 
use and formal employment with alcohol use. 
(Hauli et al., 2011). In a South African study, 
younger age and involuntary admissions were 
associated with substance use disorders (Weich 
and Pienaar, 2009). However, studies examin-
ing the correlates of hazardous substance use in 
psychiatric patients have been largely limited 
to western countries (Cruce et al., 2007). For 
example, a study in Norway found that female 
gender and smokers were significantly linked 
to drug related problems among persons with 
mental disorders (Cruce et al., 2007). 
Previous studies of prevalence rates sub-
stance use among patients in Nigerian psychi-
atric facilities are few and limited to persons 
admitted into alcohol and drug treatment units 
(Adamson and Akindele, 1994 ; Adamson et 
al., 2010). Apart from persons with substance 
dependence requiring treatment and rehabilita-
tion at psychiatric hospitals (Adelekan, 1996), 
persons with non-dependent substance use oc-
curring with mental illness may also be pres-
ent at such facilities (Cruce et al., 2007; Hauli 
et al., 2011). It is important to examine men-
tally ill persons with or without co-occurring 
substance dependence in view of the signifi-
cant morbidity and mortality reported among 
non-dependent substance users (Dengerhadt et 
al., 2001). The use of alcohol and other drugs 
even among non-dependent individuals may 
significantly increase risk for violence, impair 
treatment compliance, and worsen outcome of 
mental illness (Koskinen et al., 2009). 
In developing countries like Nigeria, the 
financial burden of providing care for the 
mentally ill is quite high (Amoo, 1998). This 
is compounded by limited access to mental 
health services due to inadequate facilities 
and qualified staff. Evaluating the prevalence 
of substance use among persons with mental 
disorders would provide relevant data and fa-
cilitate optimal use of the limited healthcare 
resources available in the country. In view of 
this, this study aimed to determine the preva-
lence and correlates of substance use among 
persons with mental disorders in a Nigerian 
Psychiatric Hospital. We hypothesized that 
gender, age, marital status, employment sta-
tus and educational level would be associated 
with substance use among patients.
MethoD
Study design and sample selection
This was a cross-sectional study of persons 
with mental disorders presenting for evalu-
ation and treatment at the Neuropsychiatric 
hospital, Aro between December, 2011 and 
February, 2012. The hospital has 10 wards in-
cluding a drug abuse treatment facility. It is a 
government owned specialist tertiary institu-
tion located in south-western Nigeria. It pro-
vides in-patient, outpatient, and 24-hour emer-
gency services to mentally ill patients. Most of 
the attending patients have major psychiatric 
disorders like schizophrenia, affective disor-
ders and substance use disorders. 
All patients aged 18-64 years attending out-
patient clinic or on admission during the pe-
riod of the study were eligible to participate 
in the study. These included patients with sub-
stance use disorders admitted in the hospital. 
Patients that were too ill or refused to give 
consent were excluded from the study. Pa-
tients attending the psychiatric hospital within 
the study period that met the inclusion criteria 
were consecutively recruited.
instruments
A Sociodemographic questionnaire was 
used to elicit the socio-demographic charac-
teristics of the respondents in this study. It in-
cluded information on respondents’ sex, age, 




World health organization Alcohol, 
Smoking, Substance involvement 
Screening test (ASSiSt)
This interview administered screening in-
strument was developed by World Health Or-
ganization (WHO) to detect psychoactive sub-
stance use and associated problems including 
intoxications and dependence in patients (Hu-
meniuk et al., 2010). It was used to assess drug 
use in respondents’ lifetime and past 3 months. 
Questions 2-7 were scored for each substance 
and the resultant substance involvement score 
computed. The scores were categorized into 3 
levels of risk: Low risk (0-3), Moderate risk 
(4-26) and High risk (27+). Question 8 as-
sessed injecting drug use which is an indicator 
of risk. The ASSIST has been validated in sev-
eral countries (Group W.A.W, 2002). Respon-
dents were divided into two groups for further 
analysis. Those with substance involvement 
score of 3 or below were categorized as non-
hazardous substance users while those with 
scores greater than 3 were categorized as haz-
ardous substance users. 
The instrument was translated into Yoruba 
(the predominant language spoken in south-
western Nigeria) and modified to include local 
names of common psychoactive substances. 
Also, the interviewers had received prior train-
ing in administering the instrument before 
commencement of the study.
ethical consideration
All out- and inpatients in treatment contact 
with the hospital were invited to participate in 
the study after the objectives were explained. 
Written informed consent was obtained from 
the participants. Ethical approval was granted 
by the Ethics review board of Neuropsychiat-
ric hospital, Aro, Abeokuta.
Data analysis
Data was analysed with SPSS version 16 
(SPSS, Chicago IL, USA). Differences be-
tween groups were examined for statistical 
significance using Chi square test for cat-
egorical variables with Yates’ Correction or 
Fisher Exact Test (FET) implemented where 
appropriate while continuous variables like 
age were analysed with independent t-test. 
The level of significance (p) was set at < 0.05. 
Significant variables in the univariate analysis 
were entered into a logistic regression analysis 
to determine variables independently associ-
ated with hazardous substance use. Odds ratio 
(OR) with 95% Confidence Interval (CI) were 
then calculated for the independently associ-
ated variables.
reSultS
Out of 111 patients approached, 105 agreed 
to participate in the study. The mean age of the 
subjects was 31.8 (SD =8.6) years. The age 
range was 19-56years.
Majority of the subjects were males 
(85.7%), never married (70.5%), employed 
(50.5%) and had less than secondary school 
education (61.9%) (Table 1).
The prevalence rates of substances used are 
as presented in Table 2. Eighty seven patients 
(82.9%) had used substances in their lifetime. 
The highest lifetime prevalence of psychoac-
tive substance use was reported with alcohol 
(78.1%) followed by tobacco (59%), canna-
bis (53.3%), cocaine (6.7%), opioids (6.7%), 
sedatives (4.8%), solvents (3.8%) and amphet-
amine (2.9%). More than a third of alcohol 
(44.2%) and tobacco users (30.5%) and a fifth 
of cannabis users (18.2%) had initiated drug 
use during adolescence. Hazardous tobacco 
use (45.7%) in past 3 months was most com-
mon followed by alcohol (38.1%) and canna-
bis use (37.1%). Multiple substance use had 
occurred in 67 patients (63.8%).
Hazardous substance use was significantly 
associated with male sex (p < 0.05), being 
single (p < 0.01), unemployment ( p < 0.01), 
younger age (p < 0.05), and lower level of 
education (p < 0.05). Hazardous drug users 
were five times more likely to be male (OR 
5.0, 95% CI 1.32-18.9), four times more likely 
to be single (OR 4.36, 95% CI 1.70-11.01), 
unemployed (OR 4.0, 95% CI 1.78-9.01) and 
about three times more likely to have lower 
educational attainment (OR 2.79, 95% CI 1.2-
6.31) (Table 3).
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DiScuSSion
This study found a lifetime prevalence of 
82.9%. Similarly high prevalence rates have 
been reported in previous studies. About 
68.5% was reported by Hauli et al. (2011) in 
Tanzania and 74.5% by Sinclair and Latifi 
(2008) in United Kingdom. The high rate of 
substance use among psychiatric patients 
agrees with the finding in literatures. Different 
hypotheses have been suggested in an attempt 
to explain the complex relationship between 
mental disorders and substance use (Marshall 
& Farrell, 2007). These include the self-medi-
cation hypothesis (persons with mental illness 
may use substances e.g nicotine to cope with 
psychotic experiences) (Kessler et al., 1996) 
and shared-vulnerability hypothesis (common 
factors predisposing to both substance disor-
ders and mental illness) (Patel, 2007).
Alcohol was the most frequently used sub-
stance followed by Tobacco and Cannabis. 
This pattern was similarly reported by Hauli 
et al. (2011). The availability of inexpensive 
forms of these substances, inadequate en-
forcement of policies regulating their use and 
relative social acceptability make them widely 
available in Nigeria (Gureje et al., 2007; Obot, 
1990). The relationship between cannabis and 
psychotic illnesses may explain its high preva-
lence in persons presenting for psychiatric 




  16-25 26 24.8
  26-35 51 48.6
  36-45 18 17.1
  ≥ 46 10 9.5
Age (years)
  Mean ± SD =31.8 ±8.6
  Age Range 19-56
Sex
  Male 90 85.7
  Female 15 14.3
Marital Status
  Never Married 74 70.5
  Married 18 17.1
  Previously married * 13 12.4
employment Status
  Employed 52 49.5
  Unemployed 53 50.5
educational Attainment
  Below Secondary 65 61.9
  Secondary and above 40 38.9
*widowed, separated or divorced
table 2: Prevalence of substance use among the participants
Substance
lifetime use Adolescent onset hazardous drug use
n (%) n (%) n (%)
Any Substance 87 (82.9%) - 53 (50.5%)
Alcohol 82 (78.1) 46 (44.2) 40 (38.1)
Tobacco 62 (59) 32 (30.5) 48 (45.7)
Cannabis 56 (53.3) 19 (18.1) 39 (37.1)
Cocaine 7 (6.7) 0 5(4.8)
Opioids 7 (6.7) 1(1) 7 (6.7)
Sedatives 5 (4.8) 1(1) 0
Solvents 3 (3.8) 0 0
Amphetamine 3 (2.9) 0 2 (1.9)
Multiple substance use 67 (63.8%)
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treatment at a specialist hospital (Williams et 
al. 1996; Thomas, 1993; Thornicroft, 1990). 
The relatively low prevalence rates reported 
for cocaine, opioids and amphetamines com-
pared with other drugs is in keeping with the 
rates reported in previous local studies (Ad-
amson et al., 2010; Hauli et al., 2011). Pos-
sible explanations include limited availability, 
accessibility and high cost of obtaining such 
psychoactive substances (Hauli et al., 2011). 
In terms of hazardous drug use, tobacco 
was the most frequent. This is quite disturbing, 
considering the significant physical health risks 
associated with its use (Sani et al.,2006; Erha-
bor et al.,2002). Consistent with a previous 
epidemiological study (Gureje et al., 2007), 
about half of tobacco users started as adoles-
cents. Prevention efforts targeting adolescents 
may further reduce the burden of tobacco use 
in low income countries. Smoking cessation 
programmes should be integrated into mental 
health services to reduce tobacco related mor-
tality arising from the epidemic in low and 
middle income countries (WHO, 2005). 
This study found male gender, unemploy-
ment, lower level of education and marital 
status (single) to be associated with hazardous 
substance. Gender differences in substance 
use may not be unrelated to Nigerian social 
and cultural norms for men and women (Obot, 
2000). Male attributes like aggressiveness, 
sensation seeking and antisociality may con-
tribute to problematic substance use (Nolen-
Hoeksema , 2004).
This study had its limitations. Its hospital 
based and non-random nature limits gener-
alizability. The sample size limited further 
analysis of factors influencing use and abuse 
of specific psychoactive substances. Notwith-
standing these limitations, the study had its 
strengths including the use of an internation-
ally validated instrument, focus on an under-
studied population and naturalistic design.
This study showed that substance use is 
prevalent among persons presenting at Nige-
rian psychiatric hospital. Further studies are 
required to evaluate risk factors for hazard-
ous use of specific psychoactive substances 





c2 df P or (95% ci)
Sex
  Male 40 (44.4) 50 (55.6) 5.16 1 0.023* 5 (1.32-18.9)
  Female 12 (80) 3 (20) 1
employment status
  Unemployed 17 (32.7) 35(67.3) 10.4 1 0.001** 4.0 (1.78-9.01)
  Employed 35 (66.0) 18 (34.0) 1
Marital status
  Never married 29 (39.7) 44 (60.3) 9.01 1 0.003** 4.36 (1.71-11.07)
  Ever Married 23 (74.2) 8 (25.8) 1
educational status
  Below Secondary 26 (40) 39 (60) 5.23 1 0.022* 2.79 (1.23-6.31)
  Secondary and above 26 (65) 14 (35) 1
continuous variables S.e t df p
  Mean Age 33.7±9.5 29.9±7.2 1.65 2.26 102 0.026*
* p < 0.05 **p < 0.01
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among persons with mental disorders. Routine 
screening and brief interventions for substance 
use in psychiatric facilities should be critical 
components of mental health service delivery.
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